Harvard Bioscience Insider Ups Holding During Year
Holley And 2 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interes
Harvard Bioscience(HBIO.US) Officer Buys US$29,100 in Common Stock
$Harvard Bioscience(HBIO.US)$ Officer Green James W purchased 10,000 shares of common stock on Jun 13, 2024 at an average price of $2.91 for a total value of $29,100.Source: Announcement What is state
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interes
Harvard Bioscience(HBIO.US) Officer Buys US$61,400 in Common Stock
$Harvard Bioscience(HBIO.US)$ Officer Green James W purchased 20,000 shares of common stock on Jun 6, 2024 at an average price of $3.07 for a total value of $61,400.Source: Announcement What is statem
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be
Harvard Bioscience, Inc. to Participate in The Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.
Harvard Bioscience | 10-Q: Quarterly report
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02
07:18 AM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02
Express News | Harvard Bioscience - Expect H2 Growth Vs Both H1 of 2024 and H2 2023, Supported by New Product Commercializations & Expected Improvements in China
Express News | Harvard Bioscience Inc - for Full Year 2024 We Expect Revenues to Be Approximately Flat Versus 2023
Express News | Harvard Bioscience Continues To Expect 2024 Gross Margin Of Approximately 60% And Adjusted EBITDA Margin In The Mid-teens
Harvard Bioscience Sees FY24 Revenues Approximately Flat Versus 2023 >HBIO
Harvard Bioscience Sees FY24 Revenues Approximately Flat Versus 2023 >HBIO
Express News | Harvard Bioscience Announces First Quarter 2024 Financial Results
Express News | Harvard Bioscience Q1 Revenue USD 24.5 Million
Harvard Bioscience 1Q Adj EPS 2c >HBIO
Harvard Bioscience 1Q Adj EPS 2c >HBIO
Press Release: Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) wil
Harvard Bioscience Announces Labor Force Reduction